logo_image
Headline: SIGA Announces New Drug Application Filing with FDA for Intravenous Formulation of TPOXX
Location: New York, NY, US
Post Date: May 4, 2021 7:30 AM
TAG ID: pznews229987
DocID: 202105048228362-en.xml
Word Count: approx. 937 words
 
SIGA Announces New Drug Application Filing with FDA for Intravenous Formulation of TPOXX - Important for Patients Who Cannot Swallow Oral Capsules -
 
Please login to download this Story